1. Pharmacological evidence: a new therapeutic approach to the treatment of chronic heart failure through SUR2B/Kir6.1 channel in endothelial cells
   Shang Wang et al, 2017, Acta Pharmacologica Sinica CrossRef
2. Xin-Ji-Er-Kang Alleviates Myocardial Infarction-Induced Cardiovascular Remodeling in Rats by Inhibiting Endothelial Dysfunction
   Pan Cheng et al, 2019, BioMed Research International CrossRef
3. KATP channels are regulators of programmed cell death and targets for the creation of novel drugs against ischemia/reperfusion cardiac injury
   Leonid N. Maslov et al, 2023, Fundamental & Clinical Pharmacology CrossRef
4. Tongguan capsule derived-herb ameliorates remodeling at infarcted border zone and reduces ventricular arrhythmias in rats after myocardial infarction
   Shiyu Ma et al, 2019, Biomedicine & Pharmacotherapy CrossRef
5. SUR2B/Kir6.1 channel openers correct endothelial dysfunction in chronic heart failure via the miR-1-3p/ET-1 pathway
   Shang Wang et al, 2019, Biomedicine & Pharmacotherapy CrossRef
6. Research progress on the natural products in the intervention of myocardial infarction
   Qiuting Guo et al, 2024, Frontiers in Pharmacology CrossRef
7. Role of PKA in the process of neonatal cardiomyocyte hypertrophy induced by urotensin II
   Jianrong Xu et al, 2017, International Journal of Molecular Medicine CrossRef
8. Tongguan capsule‐derived herb reduces susceptibility to atrial fibrillation by inhibiting left atrial fibrosis via modulating cardiac fibroblasts
   Shiyu Ma et al, 2019, Journal of Cellular and Molecular Medicine CrossRef